| Literature DB >> 24791011 |
Jana Blahova1, Helena Modra1, Marie Sevcikova1, Petr Marsalek1, Lenka Zelnickova1, Misa Skoric2, Zdenka Svobodova1.
Abstract
The aim of study was to evaluate the effect of atrazine exposure (5, 15, 20, and 30 mg·L(-1)) on common carp and the ability of regeneration. During 96 h exposure we observed abnormal behavior in fish exposed to 20 and 30 mg·L(-1). Mortality and histological alterations were noticed only in the group exposed to 30 mg·L(-1). Most experimental groups showed significantly (P < 0.05) lower values of haemoglobin, haematocrit, leukocyte, and lymphocyte and significantly higher values of monocytes, segmented and band neutrophile granulocytes, and also metamyelocytes and myelocytes. A significantly lower (P < 0.05) leukocyte count was also recorded in experimental groups (5 and 15 mg·L(-1)) after recovery period. Statistically significant (P < 0.05) alterations in glucose, total protein, lactate, phosphorus, calcium, and biopterin as well as in activities of ALT, AST, ALP, and LDH were found in most experimental groups. These changes were most apparent in the groups exposed to 20 and 30 mg·L(-1). Most of the indices were found to be restored after the 7-day recovery period with the exception of LDH, ALT, and lactate in the group exposed to 15 mg·L(-1). Our results showed that atrazine exposure had a profound negative influence on selected indices and also on histological changes of common carp.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24791011 PMCID: PMC3985192 DOI: 10.1155/2014/980948
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Experimental carp after 96 h exposure to 30 mg·L−1 of atrazine: transudate in the body cavity.
Results of haematological examination during atrazine exposure and recovery period.
| Indices | 96 h toxicity test | 7-day recovery test in pure water | ||||||
|---|---|---|---|---|---|---|---|---|
| Control | 5 mg·L−1 | 15 mg·L−1 | 20 mg·L−1 | 30 mg·L−1 | Control | 5 mg·L−1 | 15 mg·L−1 | |
| RBC (T·L−1) | 2.07 ± 0.12ab | 1.55 ± 0.16b | 2.21 ± 0.19ab | 2.49 ± 0.10a | 1.48 ± 0.46b | 1.64 ± 0.06b | 1.73 ± 0.17b | 1.75 ± 0.12ab |
| Hb (g·L−1) | 74.80 ± 1.35a | 73.48 ± 1.88a | 73.68 ± 3.63a | 75.46 ± 2.95a | 56.05 ± 7.19b | 74.80 ± 1.35a | 73.48 ± 1.88a | 73.68 ± 3.63a |
| PCV (l·L−1) | 0.24 ± 0.01b | 0.24 ± 0.01b | 0.22 ± 0.01b | 0.23 ± 0.01b | 0.18 ± 0.01a | 0.23 ± 0.01b | 0.25 ± 0.01b | 0.23 ± 0.01b |
| WBC (G·L−1) | 25.88 ± 1.73a | 13.92 ± 1.36b | 11.88 ± 1.05b | 13.36 ± 1.34b | 12.88 ± 4.30b | 21.17 ± 1.06a | 16.75 ± 2.25b | 18.10 ± 1.80b |
| Lymphocytes (G·L−1) | 7.18 ± 0.09a | 5.99 ± 0.24ab | 4.38 ± 0.31b | 3.32 ± 0.33b | 2.61 ± 0.83b | 6.73 ± 0.17a | 6.66 ± 0.13a | 7.12 ± 0.09a |
| Monocytes (G·L−1) | 0.08 ± 0.02a | 0.08 ± 0.02a | 0.14 ± 0.04a | 0.12 ± 0.04a | 0.30 ± 0.09b | 0.09 ± 0.03a | 0.10 ± 0.03a | 0.10 ± 0.03a |
| NG-Segment (G·L−1) | 0.12 ± 0.05a | 0.43 ± 0.12b | 0.52 ± 0.10b | 0.48 ± 0.15b | 0.51 ± 0.18b | 0.16 ± 0.05a | 0.21 ± 0.04a | 0.18 ± 0.05a |
| NG-Bands (G·L−1) | 0.08 ± 0.02a | 0.26 ± 0.05a | 0.72 ± 0.11b | 0.92 ± 0.12b | 1.46 ± 0.43b | 0.08 ± 0.05a | 0.12 ± 0.04a | 0.07 ± 0.02a |
| Metamyelocytes (G·L−1) | 0.11 ± 0.04a | 0.64 ± 0.10b | 1.58 ± 0.20c | 1.94 ± 0.24c | 1.83 ± 0.23c | 0.26 ± 0.08a | 0.32 ± 0.09a | 0.19 ± 0.03a |
| Myelocytes (G·L−1) | 0.09 ± 0.02a | 0.18 ± 0.06a | 0.37 ± 0.07b | 0.79 ± 0.15b | 0.85 ± 0.33b | 0.07 ± 0.02a | 0.09 ± 0.03a | 0.05 ± 0.02a |
Data are expressed as mean ± standard error of mean. Significant differences (P < 0.05) are indicated by different alphabetic superscripts (a legend: RBC: erythrocyte count; Hb: haemoglobin concentration; PCV: haematocrit value; WBC: leukocyte count; NG: neutrophile granulocytes).
Results of biochemial examination during atrazine exposure and recovery period.
| Indices | 96 h toxicity test | 7-day recovery test in pure water | ||||||
|---|---|---|---|---|---|---|---|---|
| Control | 5 mg·L−1 | 15 mg·L−1 | 20 mg·L−1 | 30 mg·L−1 | Control | 5 mg·L−1 | 15 mg·L−1 | |
| Glucose (mmol·L−1) | 3.42 ± 0.20a | 9.15 ± 0.62b | 23.03 ± 1.30c | 22.47 ± 2.32c | 28.02 ± 3.79c | 3.55 ± 0.24a | 3.55 ± 0.26a | 3.39 ± 0.23a |
| Total protein (g·L−1) | 19.59 ± 1.11a | 20.97 ± 0.91a | 26.52 ± 0.91b | 23.12 ± 1.34ab | 17.13 ± 4.7a | 22.40 ± 0.62ab | 19.36 ± 0.40a | 21.72 ± 0.47ab |
| Albumin (g·L−1) | 6.02 ± 0.39ab | 6.99 ± 0.53bc | 8.05 ± 0.29b | 3.87 ± 0.70a | 4.59 ± 2.12ac | 5.93 ± 0.40ab | 5.65 ± 0.25ac | 6.20 ± 0.32bc |
| ALT ( | 0.17 ± 0.01a | 0.27 ± 0.03acd | 0.46 ± 0.09bc | 0.50 ± 0.07bd | 0.60 ± 0.15b | 0.25 ± 0.01ac | 0.26 ± 0.02ac | 0.49 ± 0.06bd |
| AST ( | 2.33 ± 0.13a | 2.45 ± 0.38a | 3.33 ± 0.31ac | 5.15 ± 0.36b | 4.73 ± 0.67bc | 3.31 ± 0.33ac | 3.27 ± 0.14ac | 2.81 ± 0.27a |
| ALP ( | 0.21 ± 0.03a | 0.32 ± 0.05ab | 0.42 ± 0.02b | 0.37 ± 0.03bc | 0.24 ± 0.07ac | 0.30 ± 0.02ab | 0.30 ± 0.03ab | 0.35 ± 0.03bc |
| LDH ( | 3.98 ± 0.58ab | 3.02 ± 0.61ab | 4.57 ± 1.13ab | 10.15 ± 0.89c | 5.84 ± 1.35b | 5.26 ± 0.65b | 2.22 ± 0.13a | 2.02 ± 0.21a |
| Lactate (mmol·L−1) | 1.64 ± 0.30b | 0.73 ± 0.10ad | 0.90 ± 0.10ab | 0.94 ± 0.10ab | 0.40 ± 0.10a | 1.45 ± 0.20bd | 1.62 ± 0.13b | 2.63 ± 0.20c |
| Phosphorus (mmol·L−1) | 2.07 ± 0.08c | 1.28 ± 0.11ad | 1.12 ± 0.06a | 1.55 ± 0.08bd | 1.07 ± 0.10a | 1.76 ± 0.09bc | 1.62 ± 0.10bd | 1.88 ± 0.07bc |
| Calcium (mmol·L−1) | 2.04 ± 0.02bc | 2.06 ± 0.03c | 1.86 ± 0.03b | 1.52 ± 0.03a | 1.51 ± 0.03a | 1.90 ± 0.08bc | 1.91 ± 0.02bc | 2.03 ± 0.03bc |
Data are expressed as mean ± standard error of mean. Significant differences (P < 0.05) are indicated by different alphabetic superscripts (a legend: ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; LDH: lactate dehydrogenase).
Results (mean ± standard error of mean) of pterins in blood plasma during atrazine exposure and recovery period.
| Neopterin (mmol·L−1) | Biopterin (mmol·L−1) | |
|---|---|---|
| 96 h toxicity test | ||
| Control | 25.61 ± 1.36a | 47.53 ± 3.56ac |
| 5 mg·L−1 | 27.99 ± 2.81a | 49.29 ± 4.40a |
| 15 mg·L−1 | 19.09 ± 1.48a | 49.32 ± 5.71ac |
| 20 mg·L−1 | 27.22 ± 3.66a | 74.90 ± 6.24b |
|
| ||
| 7-day recovery test in pure water | ||
| Control | 24.18 ± 1.89a | 36.60 ± 3.71ac |
| 5 mg·L−1 | 21.69 ± 1.12a | 31.56 ± 2.62c |
| 15 mg·L−1 | 22.91 ± 1.63a | 34.97 ± 4.34ac |
Significant differences (P < 0.05) are indicated by different alphabetic superscripts.
Figure 2Results of histopathological examination of liver samples (arrows: diffuse hydropic to vacuolar degeneration of hepatocytes).
Figure 3Results of histopathological examination of gill samples (a: severe lamellar teleangiectasis; dilated lamellar capillaries filled with erythrocytes; b: rupture of dilated lamellar capillary and pooling of the blood with formation of thrombi).